CTRI/2020/12/029594Not yet recruiting未知
Evaluation of preoperative Tapentadol, Pregabalin and Solifenacin for catheter related bladder discomfort in patients undergoing percutaneous nephrolithotomy : A randomized controlled study
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- ONE
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients of either sex
- •Aged 18 â?? 60 years
- •Patients of American Society of Anaesthesiologists grade I & II
- •Scheduled for elective percutaneous nephrolithotomy under general anaesthesia.
Exclusion Criteria
- •Age < 18 years or > 60 years
- •Patients of American Society of Anaesthesiologists grade III & IV
- •History of significant cardiac diseases like previous MI, arrhythmias, high A V conduction blocks, uncontrolled hypertension, angina.
- •History of chronic use of beta-blockers
- •Sleep apnoea
- •Significant liver dysfunction
- •History of chronic opioid use,
- •Patients with renal failure ( higher serum creatinine levels >=1.5mg%, urine < 400mI/day), history of urinary tract obstruction / neurogenic bladder / overactive bladder (OAB) ( frequency >3 at night or >8 in 24 hours) / transurethral resection of prostate for benign prostatic hyperplasia
- •Hypersensitivity to any of the study drugs
Investigators
Similar Trials
Completed
Phase 3
Perioperative administration of Tapentadol – tolerance, safety and effectson postoperative recovery and quality of life.(PATENT)Randomized, controlled study to compare the analgesic therapy withtapentadol compared to pure opioid receptor agonistsHysterectomy with ASA 1-3R52.9Pain, unspecifiedDRKS00005432Philipps-Universität Marburg121
Active, not recruiting
Phase 1
Standard-armed controlled study to assess the impact of tapentadol administration after hysterectomy, prostatektomy or nephrektomie on quality of life and pain management as well as on safety and tolerability in comparison to a conventional pain therapy with morphine using a historical control group.Hysterectomy with ASA 1-3, Prostatectomy with ASA 1-3, Nephrectomy with ASA 1-3MedDRA version: 14.1Level: PTClassification code 10021151Term: HysterectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10029116Term: NephrectomySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 14.1Level: PTClassification code 10061916Term: ProstatectomySystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-004585-18-DEPhilipps-Universität Marburg
Not yet recruiting
Not Applicable
The benefit of using either nasal or oral preparation of Tapentadol during or after the operative procedure to decrease pain and control all other ill effects of pain.CTRI/2022/03/040865RKMSP VIMS
Completed
Not Applicable
Preemptive Tapentadol on Post-operative Analgesia Following Total Knee ArthroplastyAnalgesiaNCT03351517All India Institute of Medical Sciences, Bhubaneswar90
Recruiting
Phase 2
Effect of tapontadol and oxycodone in pain controlIRCT20190618043923N2Tabriz University of Medical Sciences60